American Society of Breast Surgeons 20th Annual Meeting

Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables efficient identification of which patients, despite symptoms suggestive of coronary artery disease (CAD), have a low risk of adverse cardiovascular events and can safely avoid invasive testing out to one year. These results from the ADVANCE trial were presented as a late-breaking trial during the American College of Cardiology’s (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans, and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging.

DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling and animation videos from within their electronic health record (EHR) to better educate patients.

A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy. The study was conducted by researchers at the Johns Hopkins Kimmel Cancer Center in an effort to further individualize therapy and avoid over-treating patients.

SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.
SyncVision iFR Co-registration from Philips Healthcare maps iFR pressure readings onto angiogram.
Greg Freiherr

As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the location of stenoses not resolved by initially performed percutaneous coronary interventions (PCIs) to relieve restricted blood flow.

Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the journal Radiology. The findings support the possibility that contrast enhancement can be omitted from routine follow-up scans.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.
Greg Freiherr

Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applications. But a new entrant, “mixed reality,” may have the inside track in the interventional suite or operating room.
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.
Greg Freiherr

Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echocardiograpy. And machine learning, which is part of artificial intelligence (AI), is just getting started.

Calcium is a critical signaling molecule for most cells, and it is especially important in neurons. Imaging calcium in brain cells can reveal how neurons communicate with each other; however, current imaging techniques can only penetrate a few millimeters into the brain.

Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory requirements for three new image processing and software advancements for its digital mammography system, Aspire Cristalle. Specifically, S-View, Iterative Super-resolution Reconstruction (ISR) and Tomosynthesis Spot — innovative tools designed to meet the dual challenge of higher image quality and lower dose — are now commercially available in the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now